Eli Lilly and Nvidia are teaming up to create a powerful supercomputer and AI factory to speed up drug discovery in the pharmaceutical industry. The tools are expected to be fully operational in January, but significant benefits may not be seen until 2030. AI is being used to accelerate drug development and reduce costs.

The supercomputer will be powered by over 1,000 Blackwell Ultra GPUs from Nvidia and will assist in training AI models at scale for drug discovery. Eli Lilly plans to use the technology to discover new molecules and expand access to drug discovery tools through the Lilly TuneLab platform, which was launched in September.

The partnership between Eli Lilly and Nvidia aims to accelerate precision medicine by using AI to develop new biomarkers and provide personalized care. The supercomputer will also help shorten drug development timelines and bring treatments to patients faster. Precision medicine tailors treatment according to individual genetic and lifestyle differences.

Read more at CNBC: Eli Lilly, Nvidia to build supercomputer, AI factory for drug discovery